|

Daratumumab/rHuPH20 Co-formulation Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Daratumumab and Hyaluronidase-fihj, Darzalex FASPRO

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.